Identification and Characterization of IMD-0354 as a Glutamine Carrier Protein Inhibitor in MelanomaIMD-0354, a Glutamine Carrier Protein Inhibitor in Melanoma

Overview of attention for article published in Molecular Cancer Therapeutics, February 2021

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (96th percentile)
High Attention Score compared to outputs of the same age and source (98th percentile)

So far, Altmetric has seen 11 news stories from 10 outlets.

Robot Heal Thyself Nanoengineers develop self-repairing microbots Living tissue can heal itself from many injuries, but giving…

Grazie ad un lavoro di ricerca dei ricercatori del Sanford Burnham Prebys Medical Discovery Institute, è stato possibile…

Scientists have identified a drug candidate that blocks the uptake of glutamine, a key food source for many tumors, and slows…

San Diego restaurant and hospitality group acquires historic Lafayette Hotel for $25.8 million San Diego-based restaurant and…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity, including 7 additional news stories.